Loading clinical trials...

PRimary Prevention Of Depression in Offspring of Depressed Parents | Clinical Trials | Clareo Health

COMPLETEDNA

PRimary Prevention Of Depression in Offspring of Depressed Parents

NCT02115880•Ludwig-Maximilians - University of Munich

Summary

The purpose of this randomised controlled trial is to see whether a group-based psychological intervention for families can reduce the inflated risk of depression in children and adolescents who have at least one parent who suffers from depression (or who has suffered from depressed in the child's lifetime).

Eligibility

Age

8 - 17 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•At least one parent who meets diagnostic criteria for a current (or past, during the child's lifetime) diagnosis of depression
•The participating child is aged 8-17
•The participating child has an IQ of at least 85
•Both child and parent(s) have adequate German-language skills
•Both child and parents consent to intervention sessions being video-recorded

Exclusion Criteria

•The participating parent(s) has current symptoms of bipolar disorder, psychotic symptoms, personality disorder, substance addiction, or is suicidal
•The participating child meets criteria for a current, or previous, episode of any psychiatric disorder
•The participating child is undergoing or has undergone treatment for depression
•The participating child or parent have serious symptoms of a disorder (or are in crisis) that may hamper their ability to take part in the study

Locations (1)

Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy

Munich, Bavaria, Germany

Key Dates

Start Date

May 1, 2014

Primary Completion Date

February 1, 2019

Completion Date

February 1, 2019

Last Updated

December 13, 2023

Enrollment

100

ACTUAL participants

Conditions

Depression

Interventions

Prevention programme

BEHAVIORAL

ACT Together: Implementing a Web-Based Program With Brief Coaching for Parents of Children With Disabilities in Pediatric Outpatient Clinics

NCT07360600

ParentsChildren With Disabilities+2 more

View study

RECRUITINGPHASE3

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

NCT06793397

Major Depressive Disorder (MDD)Depression in Adults+4 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 13, 2023Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

PRimary Prevention Of Depression in Offspring of Depressed Parents

Inclusion Criteria

Exclusion Criteria

ACT Together: Implementing a Web-Based Program With Brief Coaching for Parents of Children With Disabilities in Pediatric Outpatient Clinics

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

Readiness and Progress in Emotion Regulation Therapy

Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease

A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression

Serotonin-norepinephrine Reuptake Inhibitor in Prophylaxis of Depression Following Fragility Fractures